This company seems to have been delisted
Reason: Acquired by AbbVie
Last recorded trade on: April 12, 2024
Source: https://news.abbvie.com/2024-02-12-AbbVie-Completes-Acquisition-of-ImmunoGen
Reason: Acquired by AbbVie
Last recorded trade on: April 12, 2024
Source: https://news.abbvie.com/2024-02-12-AbbVie-Completes-Acquisition-of-ImmunoGen
ImmunoGen
IMGN
$44.55
Share price
0.00%
Change (1 day)
145.75%
Change (1 year)
Categories
ImmunoGen (IMGN) - Total debt
Total debt on the balance sheet as of September 2023 : C$0.12 Billion
According to ImmunoGen 's latest financial reports the company's total debt is C$0.12 Billion. A company’s total debt is the sum of all current and non-current debts.
ImmunoGen - Total debt on balance sheet (from 1996 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | C$20.68 M | -13.58% |
| 2021-12-31 | C$23.93 M | -21.42% |
| 2020-12-31 | C$30.46 M | -13.13% |
| 2019-12-31 | C$35.06 M | 1147.12% |
| 2018-12-31 | C$2.81 M | 9.09% |
| 2017-12-31 | C$2.57 M | |
| 2016-06-30 | C$0.12 B | |
| 2001-06-30 | C$0.01 M | -97.89% |
| 2000-06-30 | C$0.58 M | 97.96% |
| 1999-06-30 | C$0.29 M | 100.12% |
| 1998-06-30 | C$0.14 M | -46.72% |
| 1997-06-30 | C$0.27 M | -94.81% |
| 1996-06-30 | C$5.31 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | C$0.16 B | 34.57% | 🇺🇸 USA |
 | C$85.73 B | 71,166.45% | 🇺🇸 USA |
 | C$47.99 B | 39,795.89% | 🇺🇸 USA |
 | C$73.04 B | 60,613.86% | 🇺🇸 USA |
 | C$52.26 B | 43,341.24% | 🇺🇸 USA |
 | C$90.80 B | 75,376.11% | 🇺🇸 USA |
 | C$44.59 B | 36,966.29% | 🇨🇭 Switzerland |
 | C$26.58 B | 21,995.70% | 🇫🇷 France |